phrykt

GE HealthCare Technologies Inc. (GEHC): who owns it and who trades it

As of Nov 16, 2026, GEHC insiders reported 8 purchases worth $6.4M in the last 12 months. The largest buyer was H Lawrence Culp Jr (Director), with $5M. 9 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling GE HealthCare Technologies

From the latest filings

Overall: more buying than selling. Famous investors mostly sold. Insiders mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, GEHC insiders reported $6.4M of open-market purchases and $0 of sales.

Purchases, 12 months
$6.4M
8 trades, 8 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
May 22, 2026
Filed May 26, 2026

Purchases and sales by month

$6.1M$6.1MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
May 22, 2026Kevin LoboDirectorPurchase10,000$64.18$642KForm 4
May 12, 2026Rodney F HochmanDirectorPurchase1,618$62.03$100KForm 4
May 8, 2026Watkin Phoebe L. YangDirectorPurchase1,000$63.01$63KForm 4
May 6, 2026H Lawrence Culp JrDirectorPurchase80,805$61.88$5MForm 4
May 6, 2026William J StrombergDirectorPurchase1,000$61.69$61.7KForm 4
May 1, 2026James SaccaroCFOPurchase3,310$60.60$201KForm 4
Apr 30, 2026Frank R JimenezGC & Corporate SecretaryPurchase1,750$60.45$106KForm 4
Apr 30, 2026Peter J ArduiniCEOPurchase4,169$59.93$250KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
H Lawrence Culp JrDirector$5M–May 6, 2026
Kevin LoboDirector$642K–May 22, 2026
Peter J ArduiniPresident and CEO, Director$250K–Apr 30, 2026
James SaccaroChief Financial Officer$201K–May 1, 2026
Frank R JimenezGC & Corporate Secretary$106K–Apr 30, 2026
Rodney F HochmanDirector$100K–May 12, 2026
Watkin Phoebe L. YangDirector$63K–May 8, 2026
William J StrombergDirector$61.7K–May 6, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

GEHC short interest

Low short interest. 4.0% of GEHC shares are sold short: about 1 share in 25. Over the last 12 reports the number of shares short went up 50%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 18.26M GEHC shares were sold short, 4.0% of the shares outstanding, down 5.8% from the report before. At the average daily volume of 3.75M shares, buying them all back would take about 4.9 trading days (days to cover).

Shares short, % of all shares

4.04%May 15Oct 304.53%

Days to cover

4.9May 15Oct 308.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202618.26M4.04%-6%3.75M4.9
Oct 15, 202619.37M4.29%+5%3.78M5.1
Sep 30, 202618.52M4.10%+10%3.96M4.7
Sep 15, 202616.91M3.74%-11%3.05M5.5
Aug 31, 202618.96M4.20%+9%2.53M7.5
Aug 14, 202617.43M3.86%-10%2.96M5.9
Jul 31, 202619.39M4.29%+5%6.58M2.9
Jul 15, 202618.45M4.06%+28%4.79M3.9
Jun 30, 202614.37M3.16%-8%5.67M2.5
Jun 15, 202615.58M3.42%+6%4.35M3.6
May 29, 202614.67M3.23%+20%4.99M2.9
May 15, 202612.18M2.68%+1%6.14M2.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded GEHC

Since Nov 17, 2024, 5 members of Congress reported 3 purchases and 4 sales of GEHC. The latest was a purchase by Alan Armstrong on Mar 27, 2026, reported Jul 21, 2026.

Purchases 3Sales 4

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Mar 25, 2026Terri A. Sewell (D-AL)Sale$1K–$15KSelfApr 21, 2026Report
Mar 23, 2026Warren Davidson (R-OH)Sale$1K–$15KSelfMar 25, 2026Report
May 15, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMay 31, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfApr 28, 2025Report
Mar 27, 2025Austin Scott (R-GA)Sale$1K–$15KSpouseAug 13, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMar 27, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

GE HealthCare Technologies company events

GE HealthCare Technologies filed 14 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026LeadershipTaha Kass-Hout notified GE HealthCare Technologies Inc. that he will resign as Chief Science and Technology Officer. Filing
  2. Oct 28, 2026LeadershipJeannette Bankes notified GE HealthCare that she will resign as President and CEO, Patient Care Solutions. Filing
  3. Sep 22, 2026LeadershipThe Board of Directors of GE HealthCare Technologies Inc. appointed Pascal Desroches to serve as a director of the Company, effective January 4, 2027. Filing
  4. Aug 18, 2026LeadershipThe Board of Directors of GE HealthCare Technologies Inc. appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026. Filing
  5. Jul 29, 2026AnnouncementShared information with investors. Filing
  6. Jul 29, 2026ResultsReleased financial results. Filing
  7. Jul 23, 2026LeadershipJames K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry. Filing
  8. May 11, 2026AnnouncementThe Company’s Board of Directors appointed Rodney F. Hochman as the Board's independent lead director and appointed Anne T. Madden as chairperson of the Nominating and Governance Committee of the Board. Filing
  9. Apr 29, 2026ResultsReleased financial results. Filing
  10. Mar 17, 2026LeadershipThe Board of Directors of GE HealthCare Technologies Inc. appointed Kevin A. Lobo to serve as a director of the Company, effective immediately. Filing
  11. Feb 27, 2026AgreementGE HealthCare Technologies Inc. entered into a 364-Day Revolving Credit Agreement among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5… Filing
  12. Feb 4, 2026ResultsReleased financial results. Filing
  13. Dec 15, 2025AgreementGE HealthCare Technologies Inc. entered into a three-year senior unsecured term loan credit facility among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein. Filing
  14. Dec 2, 2025AnnouncementGE HealthCare Technologies Inc. commenced and priced an underwritten offering of $600 million of 4.150% Notes due December 15, 2028 and $650 million of 4.950% Notes due December 15, 2035 pursuant to the registration statement on Form S-3 (File No. 333-280584), filed with the Securities and Exchange… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

GE HealthCare Technologies financials

Famous investors that hold GEHC

9 of the 50 well-known investors we track reported holding GEHC in their latest 13F filing. The largest position is Bill Nygren's, worth $971M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Bill Nygren · Harris Associates (Oakmark)Q3 202614.85M$971M1.3%-3%
Nelson Peltz · Trian Fund ManagementQ3 20263.09M$202M7.8%No change
Ken Griffin · Citadel AdvisorsQ3 20261.74M$114M0.1%-26%
Richard Pzena · Pzena Investment ManagementQ3 20261.26M$82.1M0.2%New
Israel Englander · Millennium ManagementQ3 2026796,855$52.1M0.0%+175%
Steve Cohen · Point72 Asset ManagementQ3 2026568,710$37.2M0.1%-51%
Jeremy Grantham · GMOQ3 2026439,188$28.7M0.1%+10%
Ray Dalio · Bridgewater AssociatesQ3 202614,808$968K0.0%-5%
Ken Fisher · Fisher Asset ManagementQ3 20263,123$204K0.0%-15%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about GE HealthCare Technologies Inc. (GEHC) stock

Are GEHC insiders buying or selling?

In the last 12 months, GEHC insiders reported 8 open-market purchases worth $6.4M and no sales. The latest trade was on May 22, 2026. See every trade.

What is the short interest in GEHC?

As of Oct 30, 2026, 18.26M GEHC shares were sold short, 4.0% of the shares outstanding, down 5.8% from the report before. At the average daily volume of 3.75M shares, buying them all back would take about 4.9 trading days (days to cover). See the history.

Have members of Congress traded GEHC?

Yes. 5 members of Congress reported 3 purchases and 4 sales of GEHC since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.

Which famous investors hold GEHC?

9 of the 50 well-known investors we track reported GEHC in their latest 13F filing, including Bill Nygren, Nelson Peltz, Ken Griffin. The largest position is worth $971M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.